Researchers develop new PET scanning probe that will allowing monitoring of the immune system

Researchers at UCLA's Jonsson Comprehensive Cancer Center have modified a common chemotherapy drug to create a new probe for Positron Emission Tomography (PET), an advance that will allow them to model and measure the immune system in action and monitor response to new therapies.

If you want to include this story in your blog, copy and paste this formatted text: